Home A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature
Article
Licensed
Unlicensed Requires Authentication

A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature

  • Deniz Ökdemir EMAIL logo , Nihal Hatipoğlu , Himmet Haluk Akar , Ülkü Gül , Leyla Akın , Fulya Tahan and Selim Kurtoğlu
Published/Copyright: February 23, 2015

Abstract

Gonadotropin-releasing hormone analogues are used in the treatment of prostate cancer, breast cancer, endometriosis, and uterine leiomyomas in adults and often in the treatment of precocious puberty in children. Many adverse effects have been reported for gonadotropin-releasing hormone analogues, but anaphylaxis is rarely reported as an adverse effect. Frequent cross-reactions, particularly during childhood, and diversity of the time of onset of anaphylactic manifestations complicate the diagnosis. A patient who exhibited anaphylactic allergic reactions to two different agents used in the treatment of central precocious puberty presented here because the case has an atypical course and is the first in the literature.


Corresponding author: Deniz Ökdemir, MD, Department of Endocrinology, Erciyes University Medical Faculty, Talas Street, 38039, Kayseri, Turkey, Phone: +00-90-3522076666, Fax: +00-90-3524375825, E-mail:

References

1. Fujisaki A, Kondo Y, Goto K, Morita T. Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature. Int J Urol 2012;19:81–4.10.1111/j.1442-2042.2011.02886.xSearch in Google Scholar

2. Letterie GS, Stevenson D, Shah A. Recurrent anaphylaxis to a depot form of GnRH analogue. Obstet Gynecol 1991;78:943–6.Search in Google Scholar

3. Inman M, Hursh BE, Mokashi A, Pinto T, Metzger DL, et al. Occurrence of slipped capital femoral epiphysis in children undergoing gonadotropin-releasing hormone agonist therapy for the treatment of central precocious puberty. Horm Res Paediatr 2013;80:64–8.10.1159/000351028Search in Google Scholar

4. Turk BG, Dereli T, Dereli D, Akalin T. Leuprolide acetate induced leukocytoclastic vasculitis. Acta Obstet Gynecol Scand 2007;86:892–3.10.1080/00016340600608717Search in Google Scholar

5. Makita K, Ishitani K, Ohta H, Horiguchi F, Nozawa S. Long-term effects on bone mineral density and bone metabolism of 6 months’ treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate. J Bone Miner Metab 2005;23:389–94.10.1007/s00774-005-0618-3Search in Google Scholar

6. Wilson AC, Meethal SV, Bowen RL, Atwood CS. Leuprolide acetate: a drug of diverse clinical applications. Exp Opin Invest Drugs 2007;16:1851–63.10.1517/13543784.16.11.1851Search in Google Scholar

7. Yasukawa K, Sawamura D, Sugawara H, Kato N. Leuprorelin acetate granulomas: case reports and review of the literature. Br J Dermatol 2005;152:1045–7.10.1111/j.1365-2133.2005.06341.xSearch in Google Scholar

8. Cheng A. Emergency treatment of anaphylaxis in infants and children. Paediatr Child Health 2011;16:35–40.Search in Google Scholar

9. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27:175–81.10.1111/j.1365-2222.1997.tb00690.xSearch in Google Scholar

10. Davies DM. Textbook of adverse drug reactions, 3rd ed. Oxford: Oxford University Press, 1985;130–5.Search in Google Scholar

11. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Dermatology. Berlin: Springer Verlag, 1991;210–7.10.1007/978-3-662-00181-3Search in Google Scholar

12. Lam C, Tjon J, Hamilton J, Ahmet AH. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature. Pharmacotherapy 2006;26:1811–5.10.1592/phco.26.12.1811Search in Google Scholar

13. Raj SG, Karadsheh AJ, Guillot RJ, Raj MH, Kumar P. Case report: systemic hypersensitivity reaction to goserelin acetate. Am J Med Sci 1996;312:187–90.10.1016/S0002-9629(15)41803-8Search in Google Scholar

14. Taylor JD. Anaphylactic reaction to LHRH analogue, leuprorelin. Med J Aust 1994;161:455.10.5694/j.1326-5377.1994.tb127543.xSearch in Google Scholar PubMed

15. Grant JP Jr, Levinson AW. Anaphylaxis to leuprolide acetate depot injection during treatment for prostate cancer. Clin Genitourin Cancer 2007;5:284–6.10.3816/CGC.2007.n.005Search in Google Scholar PubMed

Received: 2014-10-21
Accepted: 2015-1-9
Published Online: 2015-2-23
Published in Print: 2015-7-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Thyroid
  3. Thyroid disorders revisited
  4. Genetic analysis of the paired box transcription factor (PAX8) gene in a cohort of Polish patients with primary congenital hypothyroidism and dysgenetic thyroid glands
  5. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
  6. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients
  7. Evaluation of inflammatory and oxidative biomarkers in children with well-controlled congenital hypothyroidism
  8. Investigation of autoimmune diseases accompanying Hashimoto’s thyroiditis in children and adolescents and evaluation of cardiac signs
  9. Neonatal thyroid storm accompanied with severe anaemia
  10. Functional characterization of the novel sequence variant p.S304R in the hinge region of TSHR in a congenital hypothyroidism patients and analogy with other formerly known mutations of this gene portion
  11. Subclinical hypothyroidism as a rare cofactor in chronic kidney disease (CKD) – related anemia
  12. Cytometric analysis of perforin expression in NK cells, CD8+, and CD4+ lymphocytes in children with autoimmune Hashimoto’s thyroiditis – a preliminary study
  13. Papillary thyroid cancer and autoimmune polyglandular syndrome
  14. Review article
  15. Should radioiodine be the first-line treatment for paediatric Graves’ disease?
  16. Image in pediatric endrocrinology
  17. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease
  18. Original articles
  19. Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
  20. Rickets and vitamin D deficiency in Alaska native children
  21. Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants
  22. Parents’ experiences of having a baby with ambiguous genitalia
  23. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty
  24. Congenital adrenal hyperplasia in children – a survey on the current practice in the UK
  25. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome
  26. Influence of the body weight on the onset and progression of puberty in boys
  27. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
  28. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene
  29. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds
  30. Monitoring gonadotropin-releasing hormone analogue (GnRHa) treatment in girls with central precocious puberty: a comparison of four methods
  31. Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus
  32. Metabolic syndrome in obese children and adolescents in Serbia: prevalence and risk factors
  33. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy
  34. Patient reports
  35. 17α-Hydroylase/17,20-lyase deficiency related to P.Y27*(c.81C>A) mutation in CYP17A1 gene
  36. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature
  37. Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene
  38. Triple A syndrome with a novel indel mutation in the AAAS gene and delayed puberty
  39. Case report: long-term follow-up of a 45,X male with SHOX haploinsufficiency
  40. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review
  41. Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma
  42. Donohue syndrome: a new case with a new complication
  43. Euprolactinemic galactorrhea secondary to domperidone treatment
  44. 17βHSD-3 enzyme deficiency due to novel mutations in the HSD17B3 gene diagnosed in a neonate
  45. Two different patterns of mini-puberty in two 46,XY newborns with 17β-hydroxysteroid dehydrogenase type 3 deficiency
  46. Short communication
  47. Early onset hearing loss in autosomal recessive hypophosphatemic rickets caused by loss of function mutation in ENPP1
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0402/html
Scroll to top button